To: | Novo Nordisk A/S (trademarkdocket@whitecase.com) |
Subject: | U.S. Trademark Application Serial No. 88672347 - GEDIFORCE - 1123029NewGe |
Sent: | December 16, 2019 02:45:02 PM |
Sent As: | ecom105@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88672347
Mark: GEDIFORCE
|
|
Correspondence Address: |
|
Applicant: Novo Nordisk A/S
|
|
Reference/Docket No. 1123029NewGe
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. As agreed to by applicant’s attorney, Claudia Smith, on December 16, 2019, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id.
In addition, applicant is advised that amendments to the goods and/or services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods and/or services are not permitted. 37 C.F.R. §2.71(a).
The identification of goods is amended to read as follows:
Class 9: Downloadable computer programs for data processing; downloadable computer programs designed to estimate costs and health impact of various gestational diabetes mellitus medical screening choices
See TMEP §§1402.01, 1402.01(e). Stylized text indicates changes.
/Matthew Tully/
Matthew Tully
Trademark Examining Attorney
Law Office 105
(571) 270-5943